Specialty Pharmacy

Novartis to pay $440 million for hepatitis C drug

Feb 22, 2012

Novartis plans to pay up to $440 million for rights to a drug for treating...

FDA moves to address cancer drug shortages

Feb 21, 2012

An executive order from the Obama administration has spurred the Food and...

Pfizer cancer drug hits BioPlus' shelves

Feb 17, 2012

A specialty pharmacy provider has begun selling a drug made by Pfizer for...

Medco launches specialty benefit management program

Feb 15, 2012

Pharmacy benefit manager Medco Health Solutions has launched a medical...

Counterfeit Avastin circulating in U.S., FDA warns

Feb 15, 2012

Fake versions of a cancer drug made by Roche's U.S. unit have entered the...

OptumRx earns URAC specialty pharmacy accreditation

Feb 15, 2012

A pharmacy benefit management organization has received accreditation for...

FDA accepts Pfizer application for genetic disease drug

Feb 15, 2012

The Food and Drug Administration will review a regulatory approval...

Specialty Pharmacy Roundtable 2011

The Drug Store News Group/Specialty Pharmacy magazine hosted an exclusive executive round-table discussion of leading specialty pharmacy providers. Click here for a PDF of their discussion, including why more therapeutic classes are migrating to a specialty-preferred model, working with Medicaid, genetic testing and REMS.